Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Japan

Zydus Cadila Acquires Nippon Universal Pharmaceutical

April 2007 | Company News Alert

In an effort to penetrate the under-developed Japanese generics market, Indian firm Zydus Cadila has bought local player Nippon Universal Pharmaceutical. While a prescient move in our opinion, we believe the small-scale nature of the transaction and the languid nature of the pharmaceutical market in Japan means upside for Zydus Cadila will be modest and take some time to be realised.

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Regulatory Climate Improves

Companies / Japan BMI has reinforced its favourable assessment of Japan's regulatory environment after the country's Pharmaceuticals and Medical Devices Agency (PMDA) delineated a biosimilar approval pathway and promised...
March 2007
Speculation Mounts Over Mitsubishi/Tanabe Merger

Companies / Japan Local press, analysts and the companies themselves have increasingly commented on the possible integration of Japanese drugmakers Mitsubishi Pharma and Tanabe Seiyaku. Tanabe would acquire Mitsubishi...
January 2007
Takeda Poised For Acquisitions?

Companies / Japan In a possible change to its core growth strategy, leading Japanese drugmaker Takeda could be poised to make another large acquisition. The company - which has estimated cash reserves of more than US$14bn...
November 2006
Renewed Speculation Over Japan's Sawai

Companies / Japan Local media sources have again claimed that the world's largest generic drugmaker, Israel-based Teva, is concisidering a bid for leading Japanese generics firm Sawai. Other international producers including...
June 2006
Speculation Links Astellas, Serono

Companies / Japan Reports in the international media have prompted Astellas, Japan's third-largest drugmaker, to deny claims that the company is to use a US$8.6bn loan to acquire Swiss biotech Serono. However, officials...
March 2006


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS